Janssen Korea President takes aims Korea's top drug maker
Published: 2007-01-25 06:56:00
Updated: 2007-01-25 06:56:00
Choi Tae-hong, president of Janssen Korea, said he will aggressively revamp the company's human resources in order to make the company one of Korea's leading pharmaceutical companies in terms of revenue, profit and shareholder return.
For this year, Choi is aiming for 200 billion won, up 11.2%...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
